PL3713928T3 - Nowi antagoniści receptora bradykininy b2 - Google Patents

Nowi antagoniści receptora bradykininy b2

Info

Publication number
PL3713928T3
PL3713928T3 PL18818992T PL18818992T PL3713928T3 PL 3713928 T3 PL3713928 T3 PL 3713928T3 PL 18818992 T PL18818992 T PL 18818992T PL 18818992 T PL18818992 T PL 18818992T PL 3713928 T3 PL3713928 T3 PL 3713928T3
Authority
PL
Poland
Prior art keywords
receptor antagonists
novel bradykinin
bradykinin
novel
antagonists
Prior art date
Application number
PL18818992T
Other languages
English (en)
Inventor
Christoph Gibson
Joern SAUPE
Horst-Dieter Ambrosi
Lars Ole HAUSTEDT
Original Assignee
Pharvaris Netherlands B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharvaris Netherlands B.V. filed Critical Pharvaris Netherlands B.V.
Publication of PL3713928T3 publication Critical patent/PL3713928T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
PL18818992T 2017-11-24 2018-11-23 Nowi antagoniści receptora bradykininy b2 PL3713928T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17203675 2017-11-24
EP18818992.2A EP3713928B1 (en) 2017-11-24 2018-11-23 Novel bradykinin b2 receptor antagonists
PCT/EP2018/082338 WO2019101906A1 (en) 2017-11-24 2018-11-23 Novel bradykinin b2 receptor antagonists

Publications (1)

Publication Number Publication Date
PL3713928T3 true PL3713928T3 (pl) 2022-07-11

Family

ID=60473364

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18818992T PL3713928T3 (pl) 2017-11-24 2018-11-23 Nowi antagoniści receptora bradykininy b2

Country Status (28)

Country Link
US (3) US10836748B2 (pl)
EP (2) EP3998259A1 (pl)
JP (2) JP7164619B2 (pl)
KR (1) KR102413321B1 (pl)
CN (1) CN111433196B (pl)
AR (1) AR113839A1 (pl)
AU (1) AU2018371186B2 (pl)
BR (1) BR112020010298A2 (pl)
CA (1) CA3082948A1 (pl)
DK (1) DK3713928T3 (pl)
EA (1) EA202091256A1 (pl)
ES (1) ES2908409T3 (pl)
HR (1) HRP20220429T1 (pl)
HU (1) HUE058217T2 (pl)
IL (1) IL274883B2 (pl)
LT (1) LT3713928T (pl)
MA (1) MA50804B1 (pl)
MX (1) MX2020005287A (pl)
NZ (1) NZ764304A (pl)
PH (1) PH12020550683A1 (pl)
PL (1) PL3713928T3 (pl)
PT (1) PT3713928T (pl)
RS (1) RS63087B1 (pl)
SG (1) SG11202004653TA (pl)
SI (1) SI3713928T1 (pl)
TW (1) TWI768156B (pl)
UY (1) UY37981A (pl)
WO (1) WO2019101906A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2908409T3 (es) 2017-11-24 2022-04-29 Pharvaris Netherlands B V Antagonistas novedosos del receptor B2 de bradiquinina
AR118982A1 (es) * 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
EP4243824A1 (en) 2020-11-12 2023-09-20 Pharvaris GmbH Prophylaxis and treatment of angioedema
WO2023012324A1 (en) 2021-08-05 2023-02-09 Pharvaris Gmbh Solid form of a bradykinin b2-receptor antagonist
CA3227476A1 (en) 2021-08-05 2023-02-09 Christoph Gibson Lipid-based composition for oral administration of bradykinin b2-receptor antagonists
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
WO2023180575A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680870B2 (en) 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
CA2203659A1 (en) 1994-10-27 1996-05-09 Teruo Oku Pyridopyrimidones, quinolines and fused n-heterocycles as bradykinin antagonists
FR2737892B1 (fr) 1995-08-17 1997-10-24 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique
GB9602029D0 (en) 1996-02-01 1996-04-03 Fujisawa Pharmaceutical Co New heterocyclic compounds
DE19609827A1 (de) 1996-03-13 1997-09-18 Hoechst Ag Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten
DE19610784A1 (de) 1996-03-19 1997-09-25 Hoechst Ag Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19612067A1 (de) 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
AUPN952696A0 (en) 1996-04-29 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New heterocyclic compounds
DE19712960A1 (de) 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
AU4335299A (en) 1998-06-08 1999-12-30 Advanced Medicine, Inc. Bradykinin antagonists
IL142460A0 (en) 1998-10-21 2002-03-10 Fujisawa Pharmaceutical Co A vitreous form of 8-[3-[n-[(e)-3-(6-acetamidopyridin-3-yl) acryloyl-glycyl] -n-methylamino] -2,6-dichlorobenzyloxy]-2-methylquinoline
FR2790260B1 (fr) 1999-02-26 2001-05-04 Fournier Ind & Sante Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique
GB9913079D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US6509366B2 (en) 2000-01-18 2003-01-21 Neurogen Corporation Substituted imidazoles as selective modulators of Bradykinin B2 receptors
CA2364178C (en) 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
EP1495017A2 (en) 2002-04-10 2005-01-12 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
ITMI20021247A1 (it) 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
ITMI20041963A1 (it) 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (en) 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
TWI407960B (zh) * 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AR073304A1 (es) 2008-09-22 2010-10-28 Jerini Ag Moduladores del receptor de bradiquinina b2 de molecula pequena
KR20150127718A (ko) 2013-03-14 2015-11-17 샤이어 휴먼 지네틱 테라피즈 인크. B2-브라디키닌 수용체 매개 혈관부종의 치료 방법
ES2908409T3 (es) 2017-11-24 2022-04-29 Pharvaris Netherlands B V Antagonistas novedosos del receptor B2 de bradiquinina

Also Published As

Publication number Publication date
IL274883B2 (en) 2023-11-01
CA3082948A1 (en) 2019-05-31
UY37981A (es) 2019-06-28
JP7164619B2 (ja) 2022-11-01
KR20200094174A (ko) 2020-08-06
EP3998259A1 (en) 2022-05-18
EP3713928B1 (en) 2022-01-12
US20200255405A1 (en) 2020-08-13
EP3713928A1 (en) 2020-09-30
AU2018371186B2 (en) 2022-05-12
US20210017158A1 (en) 2021-01-21
US10836748B2 (en) 2020-11-17
PT3713928T (pt) 2022-03-08
PH12020550683A1 (en) 2021-03-15
MA50804A (fr) 2020-09-30
AR113839A1 (es) 2020-06-17
AU2018371186A1 (en) 2020-05-28
EA202091256A1 (ru) 2020-10-05
LT3713928T (lt) 2022-05-10
ES2908409T3 (es) 2022-04-29
KR102413321B1 (ko) 2022-06-24
CN111433196A (zh) 2020-07-17
JP2021504464A (ja) 2021-02-15
IL274883A (en) 2020-07-30
JP2023002701A (ja) 2023-01-10
MA50804B1 (fr) 2022-05-31
WO2019101906A1 (en) 2019-05-31
BR112020010298A2 (pt) 2020-11-17
SG11202004653TA (en) 2020-06-29
NZ764304A (en) 2024-02-23
CN111433196B (zh) 2023-06-06
TWI768156B (zh) 2022-06-21
RS63087B1 (sr) 2022-04-29
IL274883B1 (en) 2023-07-01
MX2020005287A (es) 2020-08-13
US11820756B2 (en) 2023-11-21
TW202017916A (zh) 2020-05-16
DK3713928T3 (da) 2022-04-04
HUE058217T2 (hu) 2022-07-28
US20220135543A1 (en) 2022-05-05
SI3713928T1 (sl) 2022-09-30
US11261173B2 (en) 2022-03-01
HRP20220429T1 (hr) 2022-05-27

Similar Documents

Publication Publication Date Title
IL274883A (en) BRADYKININ B2 receptor antagonists
GB201717974D0 (en) Modified receptors
IL258892B (en) Calcitonin gene-related peptide receptor antagonists
HK1249095A1 (zh) Cgrp受體拮抗劑
IL258894A (en) Cgrp receptor antagonists
IL275084A (en) Triazolobenzazepines as vasopressin V1A receptor antagonists
GB201702617D0 (en) Receptor
SG11202002207QA (en) Trpv2 antagonists
IL258893A (en) Cgrp receptor antagonists
GB201815629D0 (en) Antagonists
IL283413A (en) Antagonists
ZA201807767B (en) Angiotensin-1-receptor antagonists
IL264537A (en) Cyclic peptides as c5 a receptor antagonists
GB201707504D0 (en) Orexin receptor antagonists
GB201707499D0 (en) Orexin receptor antagonists
GB201702174D0 (en) Orexin receptor antagonists
GB201701887D0 (en) Receptor
GB201700926D0 (en) Receptor
PT3464324T (pt) Antagonistas de recetores da angiotensina-1